In this trial, the efficacy and safety of a not yet marketed gel for the treatment of 'acne vulgaris' will be assessed in comparison to the active substance.
Aged 9-50 years with 'acne vulgaris' on the face
The study will be approximately 16 weeks with up to 6 visits, including telephone checks.
Interested in finding out more about this study? Leave your contact details in our contact form or if you'd prefer, contact your nearest clinic in your own time below:
FutureMeds Liverpool Clinic - 0151 315 0090 or bridleclinic@futuremeds.com
FutureMeds Glasgow Clinic - 0141 946 7888 or info.glasgow@futuremeds.com
FutureMeds Birmingham Clinic - 0121 592 2050 or birminghamclinic@futuremeds.com
FutureMeds Teesside Clinic - 01642 843 780 or northtees@futuremeds.com
Travel expenses will be reimbursed
Participation in clinical trials provides access to innovative and potentially life-saving treatments. It also contributes to medical research, benefiting both current and future healthcare outcomes. It provides cutting-edge medical care under professional supervision and empowers individuals to contribute to the well-being of society. However, participants should carefully weigh up the risks and benefits and seek advice from their doctor before taking part in a trial.
